Fred Hutchinson Cancer Research Center clinical researcher is working to develop a biomarker test that could screen many people quickly for radiation injury after nuclear accident; could also screen patients for cancer treatment toxicity
Anne McTiernan's $250,000 grant extends her vitamin D work; Jamie Guenthoer to develop early detection blood test with $180,000 award
May 29, 2012
Drs. Anne McTiernan and Jamie Guenthoer of the Fred Hutchinson Cancer Research Center recently garnered grants from Susan G. Komen for the Cure, part of the organization's $58 million in new research funding for 2012.
Overbaugh, Cortez-led study shows women infected by two different HIV strains exhibit strong antibody response; findings may aid vaccine development
April 2, 2012
| By Kristen Woodward
Researchers at the Fred Hutchinson Cancer Research Center found that women who have been infected by two different strains of HIV from two different sexual partners-a condition known as HIV superinfection-have more potent antibody responses that block the replication of the virus compared to women who've only been infected once.
Daniel Raftery brings research on cancer metabolism and early detection, and metabolomics profiling services to the Hutchinson Center's proteomics shared resource
March 5, 2012
| By Rachel Tompa
Metabolomics expert Dr. Daniel Raftery recently joined the Fred Hutchinson Cancer Research Center faculty with an appointment in the Public Health Sciences Division. Raftery will be continuing his search, started six years ago at Purdue University, to detect the earliest stages of cancer by observing changes in cells' metabolism.
Discoveries may result in biomarker test for facioscapulohumeral muscular dystrophy, a disease that initially affects the skeletal muscles of the face, scapula and upper arms
Jan. 30, 2012
| By Dean Forbes
Continuing a series of groundbreaking discoveries begun in 2010 about the genetic causes of the third most common form of inherited muscular dystrophy, an international team of researchers led by the Hutchinson Center's Dr. Stephen Tapscott has identified the genes and proteins that damage muscle cells, as well as the mechanisms that can cause the disease.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.